Literature DB >> 29366790

Increased circular RNA hsa_circ_0012673 acts as a sponge of miR-22 to promote lung adenocarcinoma proliferation.

Xiyong Wang1, Xiaoli Zhu1, Hongming Zhang2, Shuzhen Wei3, Yan Chen4, Yang Chen4, Fei Wang5, Xiaobo Fan4, Shuhua Han3, Guoqiu Wu6.   

Abstract

Recent reports have indicated that circular RNA (circRNA) may regulate Lung adenocarcinoma (LAC) development. Our previous studies showed that hsa_circ_0012673 was up-regulated in a circRNA microarray. However, its expression level in LAC has not been verified, and the underlying molecular mechanisms in LAC are unknown. In this study, we found that the expression of hsa_circ_0012673 was up-regulated in LAC tissues compared to pair-matched adjacent non-tumor tissues (P = 0.0079), and that the expression level was associated with tumour size (P = 0.015). Furthermore, hsa_circ_0012673 was primarily localized in the cytoplasm and promoted cell proliferation of LAC cells by sponging miR-22, which targeted erb-b2 receptor tyrosine kinase 3 (ErbB3) in LAC. Hsa_circ_0012673 promotes LAC proliferation by suppressing miR-22, which targets ErbB3.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Circular RNA; ErbB3; Lung adenocarcinoma; Proliferation; hsa_circ_0012673

Mesh:

Substances:

Year:  2018        PMID: 29366790     DOI: 10.1016/j.bbrc.2018.01.126

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

1.  A novel circular RNA hsa_circ_0020123 exerts oncogenic properties through suppression of miR-144 in non-small cell lung cancer.

Authors:  Danhua Qu; Bingdi Yan; Rui Xin; Tiangang Ma
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

2.  Research progress of circular RNAs in lung cancer.

Authors:  Yi Ma; Xin Zhang; Yi-Zhi Wang; Hao Tian; Shun Xu
Journal:  Cancer Biol Ther       Date:  2018-11-07       Impact factor: 4.742

3.  Emerging roles of circRNA_NEK6 targeting miR-370-3p in the proliferation and invasion of thyroid cancer via Wnt signaling pathway.

Authors:  Fukun Chen; Zhiping Feng; Jialun Zhu; Pengjie Liu; Chuanzhou Yang; Rongkai Huang; Zhiyong Deng
Journal:  Cancer Biol Ther       Date:  2018-09-12       Impact factor: 4.742

4.  TWIST1 regulation of circRNA: a novel mechanism to promote epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors:  Zachary A Yochum; Timothy F Burns
Journal:  Noncoding RNA Investig       Date:  2018-12-19

Review 5.  Circular RNAs: pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer.

Authors:  Chunyan Li; Lin Zhang; Guangping Meng; Qi Wang; Xuejiao Lv; Jie Zhang; Junyao Li
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-19       Impact factor: 4.553

6.  Hsa_circ_0000467 promotes cancer progression and serves as a diagnostic and prognostic biomarker for gastric cancer.

Authors:  Jun Lu; Peng-Yang Zhang; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Qi-Yue Chen; Long-Long Cao; Chang-Ming Huang; Ping Li; Chao-Hui Zheng
Journal:  J Clin Lab Anal       Date:  2018-11-21       Impact factor: 2.352

7.  Circ-GSK3B up-regulates GSK3B to suppress the progression of lung adenocarcinoma.

Authors:  Ming-Chuang Zhu; Yan-Hong Zhang; Peng Xiong; Xiao-Wu Fan; Guo-Liang Li; Min Zhu
Journal:  Cancer Gene Ther       Date:  2022-07-11       Impact factor: 5.854

8.  Circular RNA (circ)_0129047 upregulates bone morphogenetic protein receptor type 2 expression to inhibit lung adenocarcinoma progression by sponging microRNA (miR)-1206.

Authors:  Xinxin Xue; Yajun Chen
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

9.  Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.

Authors:  Lei Gao; Ling Zhang
Journal:  BMC Cancer       Date:  2021-07-23       Impact factor: 4.430

Review 10.  Circular RNAs in Lung Cancer: Recent Advances and Future Perspectives.

Authors:  Huan-Huan Chen; Tie-Ning Zhang; Qi-Jun Wu; Xin-Mei Huang; Yu-Hong Zhao
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.